Single dose of AZD7442 effectively prevents COVID-19
A single dose of AZD7442 is effective for preventing COVID-19, according to a study published online April 20 in the New England Journal of Medicine.
Apr 22, 2022
0
5
A single dose of AZD7442 is effective for preventing COVID-19, according to a study published online April 20 in the New England Journal of Medicine.
Apr 22, 2022
0
5
Almost one in three patients surviving a stroke of unknown cause have atrial fibrillation (AF) detectable using continuous cardiac monitoring, according to a study presented at the annual meeting of the European Heart Rhythm ...
Apr 5, 2022
0
5
The vaccine effectiveness (VE) of Ad26.COV2.S was stable over six months, including during a period of delta variant predominance, according to a study published online March 17 in JAMA Network Open.
Mar 22, 2022
0
3
For patients with previously untreated metastatic or unresectable melanoma, the combination of relatlimab + nivolumab continues to demonstrate a progression-free survival (PFS) benefit over nivolumab alone, according to updated ...
Mar 21, 2022
0
13
For nonhospitalized patients with symptomatic mild-to-moderate COVID-19 and a high risk for progression, risk for all-cause hospitalization or death is reduced with sotrovimab versus placebo, according to a study published ...
Mar 18, 2022
0
12
(HealthDay)—Daily oral perampanel is generally well tolerated, with favorable retention rates among patients with epilepsy aged 1 to younger than 18 years, according to a study recently published in the Journal of Child ...
Mar 17, 2022
0
7
(HealthDay)—Stability in body mass index (BMI) over time is associated with a better cognitive trajectory in older adults, according to a study published online Jan. 20 in Alzheimer's & Dementia.
Jan 25, 2022
0
16
(HealthDay)—Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous ...
Jan 21, 2022
0
50
(HealthDay)—Among patients with bone and brain metastases who died within 90 days of radiotherapy receipt, 21.6 percent received guideline-nonconcordant therapy, according to a research letter published online Jan. 14 in ...
Jan 18, 2022
0
14
(HealthDay)—During the course of a 40-year career, female physicians are estimated to earn $2 million less than male physicians, according to a study published in the December issue of Health Affairs.
Dec 7, 2021
0
2